SHKNSES H Kelkar and Company Limited· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 6 Feb, 2026 · 20:06 IST

Q3 results: Rs 32.6 cr PAT, Re 1 interim dividend, Keva ME investment

Exceptional ItemRelated Party TransactionsResults View source PDFExplain this filing

SHK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.9%Reaction day
₹169.30
prior close
₹171.90
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.6%+1.3% vs market
Specialty Chemicals peers, median of 88sector+1.7%+2.2% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 2.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+4.5
10m
+4.7
15m
+4.6
30m
+1.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.9+2.6+1.3+1.7+2.2
Next day
+2.8+3.6-0.8+2.4+0.4
2d
+3.4+3.1+0.3+2.5+0.9
3d
+2.8+2.6+0.2+1.3+1.5
4d
-1.1+1.1-2.1+0.0-1.1
5d
-2.8+0.3-3.2-1.5-1.4
1w
-2.9+1.6-4.5-0.6-2.3
15d
-14.8-3.9-10.8-6.4-8.4
1m
-23.2-8.1-15.1-8.8-14.4
2m
-19.1-3.1-16.0-4.6-14.5
3m
-10.9+9.2-20.0+5.9-16.7
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 88Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

S H Kelkar Q3 FY26 consolidated revenue rose to Rs 583.80 cr from Rs 543.21 cr YoY. Q3 PAT at Rs 32.63 cr; 9M PAT swung to Rs 67.35 cr profit from Rs 28.43 cr loss, aided by Rs 35.92 cr net exceptional gain from Vashivali fire insurance recovery. 9M revenue at Rs 1,718.32 cr vs Rs 1,556.02 cr. Board declared Re 1 per share interim dividend (10%), record date Feb 13. Approved up to AED 5 million investment in Keva Middle East FZE. Unmodified auditor review.

Likely market impact

Positive on dividend and insurance recovery; underlying PBT before exceptional items fell, so core business remains weak.